Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.

MLA

Nagai, Sonoko, et al. “Open-Label Compassionate Use One Year-Treatment with Pirfenidone to Patients with Chronic Pulmonary Fibrosis.” Internal Medicine (Tokyo, Japan), vol. 41, no. 12, Dec. 2002, pp. 1118–23. EBSCOhost, https://doi.org/10.2169/internalmedicine.41.1118.

APA

Nagai, S., Hamada, K., Shigematsu, M., Taniyama, M., Yamauchi, S., & Izumi, T. (2002). Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. Internal Medicine (Tokyo, Japan), 41(12), 1118–1123. https://doi.org/10.2169/internalmedicine.41.1118

Chicago

Nagai, Sonoko, Kunio Hamada, Michio Shigematsu, Masayosi Taniyama, Shitotomo Yamauchi, and Takateru Izumi. 2002. “Open-Label Compassionate Use One Year-Treatment with Pirfenidone to Patients with Chronic Pulmonary Fibrosis.” Internal Medicine (Tokyo, Japan) 41 (12): 1118–23. doi:10.2169/internalmedicine.41.1118.